Jim Young

Track

Insider profile

Currently holds a position at Novavax Inc

Performance

Overall performance
3.0
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -19% 8.2% 15.1%
Success rate 71% 68% 82%
Transactions
15 7% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 131%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Independent Chairman of the Board Novavax Inc April 19, 2011 -
Jim Young's trades of Novavax Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-05-19 2025-05-19
US Novavax Inc (NVAX)
PrS Proposed sale
94,854
224.50
US$775,904 		94,854 224.50 US$775,904
2025-04-14 2025-04-14
US Novavax Inc (NVAX)
PrS Proposed sale
61,883
282.34
US$3,528,711 		61,883 282.34 US$3,528,711
2025-01-02 2024-12-31
US Novavax Inc (NVAX)
S Sale
54,417 -16.9%
414.32
US$3,412,089 		54,417 -16.9% 414.32 US$3,412,089
2025-01-02 2024-12-24
US Novavax Inc (NVAX)
PrS Proposed sale
10,000
8.48
US$84,800 		10,000 8.48 US$84,800
2025-01-02 2024-12-24
US Novavax Inc (NVAX)
S Sale
4,600 -7.4%
8.48
US$39,008 		4,600 -7.4% 8.48 US$39,008
2024-12-26 2024-12-24
US Novavax Inc (NVAX)
PrS Proposed sale
10,000
8.48
US$84,800 		10,000 8.48 US$84,800
2024-06-25 2024-06-21
US Novavax Inc (NVAX)
S Sale
7,500 -10.8%
14.09
US$105,675 		7,500 -10.8% 14.09 US$105,675
2024-06-21 2024-06-18
US Novavax Inc (NVAX)
S Sale
1,107 -1.6%
14.28
US$15,808 		1,107 -1.6% 14.28 US$15,808
2024-06-21 2024-06-18
US Novavax Inc (NVAX)
S Sale
6,393 -8.3%
13.62
US$87,073 		6,393 -8.3% 13.62 US$87,073
2024-06-18 2024-06-18
US Novavax Inc (NVAX)
PrS Proposed sale
15,000
13.71
US$205,650 		15,000 13.71 US$205,650
2022-04-04 2022-03-31
US Novavax Inc (NVAX)
S Sale
300 -0.5%
75.10
US$22,531 		300 -0.5% 75.10 US$22,531
2022-04-04 2022-03-31
US Novavax Inc (NVAX)
S Sale
3,255 -4.9%
74.25
US$241,684 		3,255 -4.9% 74.25 US$241,684
2022-04-04 2022-03-31
US Novavax Inc (NVAX)
S Sale
8,945 -11.9%
73.29
US$655,550 		8,945 -11.9% 73.29 US$655,550
2022-01-04 2021-12-31
US Novavax Inc (NVAX)
S Sale
3,750 -4.8%
144.16
US$540,601 		3,750 -4.8% 144.16 US$540,601
2021-03-25 2021-03-23
US Novavax Inc (NVAX)
S Sale
2,446 -19.7%
229.41
US$561,134 		2,446 -19.7% 229.41 US$561,134
2021-03-25 2021-03-23
US Novavax Inc (NVAX)
S Sale
3,120 -20.0%
228.42
US$712,661 		3,120 -20.0% 228.42 US$712,661
2021-03-25 2021-03-23
US Novavax Inc (NVAX)
S Sale
4,434 -22.2%
227.43
US$1,008,435 		4,434 -22.2% 227.43 US$1,008,435
2021-01-05 2020-12-31
US Novavax Inc (NVAX)
S Sale
2,000 -100.0%
113.60
US$227,190 		2,000 -100.0% 113.60 US$227,190
2021-01-05 2020-12-31
US Novavax Inc (NVAX)
S Sale
9,000 -81.8%
112.98
US$1,016,824 		9,000 -81.8% 112.98 US$1,016,824
2020-06-05 2020-06-03
US Novavax Inc (NVAX)
B Purchase
1,500 +inf%
48.83
US$73,245 		1,500 +inf% 48.83 US$73,245